InsidersTradesSigma
Follow the METABOLIX, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 28 January 2016 (J). Among the most active insiders: SCULLY WILLIAM P. All data is accessible without an account.
Analysts rate METABOLIX, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
METABOLIX, INC. is a company focused on developing sustainable biopolymer solutions. It is listed on NASDAQ under the ticker XNAS.